Published in

Elsevier, Annals of Oncology, 12(26), p. 2505-2506, 2015

DOI: 10.1093/annonc/mdv478

Elsevier, Annals of Oncology, 5(26), p. 873-879, 2015

DOI: 10.1093/annonc/mdv106

Links

Tools

Export citation

Search in Google Scholar

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

by guest on M arch 2, 2015